Inkcazelo emfutshane:
Inombolo ye-CAS: 665-66-7
Ifomula yemolekyuli: C10H18ClN
Ubunzima bemolekyuli: 187.71
Ubume bekhemikhali:
| Ulwazi olusisiseko | |
| Igama lemveliso | I-Amantanamine hydrochloride(iBanga lezoKhemesti) |
| Inombolo yeCAS. | 665-66-7 |
| Imbonakalo | Umgubo oMhlophe oLungileyo oyiCrystalline |
| IBanga | Pharma iBanga |
| Ukunyibilika kwamanzi | Enyibilikayo |
| Ugcino | Gcina ngaphantsi +30°C. |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Iphakheji | 25kg/Igubu |
Ingcaciso yeMveliso
| Igama lemveliso: | I-Amantanamine hydrochloride |
| Izithethantonye: | I-Amantanamine hydrochloride, i-1-Adamantylamine hydrochloride, i-1-Aminoadamantane hydrochloride; IHydrochloride (200 mg);1-AdaMantanaMine hydrochloride, 99+% 100GR;1-AdaMantanaMine hydrochloride, 99+% 25GR;1-AdaMantanaMine hydrochloride, 99+% 5GR;1-adamantane amine hydrochloridaminode1; IHydrochloride |
| I-CAS: | 665-66-7 |
| MF: | I-C10H18ClN |
| MW: | 187.71 |
| EINECS: | 211-560-2 |
| Iindidi zeeMveliso: | Iintsholongwane ze-Influenza;API;Ii-Intermediates & Fine Chemicals;iDopamine receptor;SYMADINE;inhibitor;i-Adamanane derivatives;chiral;Adamntanes;Pharmaceuticals;API's;1;665-66-7 |
Ukusetyenziswa kweKlinikhi
I-Amantanamine hydrochlorideisetyenziswa kunyango lweprophylactic okanye lweempawu zomkhuhlane A.
Ikwasetyenziswa njengearhente ye-antiparkinsonian, ukunyanga ukusabela okongezelelekileyo kwepyramidal, kunye ne-postherpetic neuralgia.
Ikwasetyenziswa i-NMDA-receptor antagoinst.
